In RA, chronic synovial and systemic inflammation serves as a core mechanism driving disease progression, involving the activation of signaling pathways such as nuclear factor-κB (NF-κB), JAK–STAT, and MAPK, as well as the engagement of inflammasomes and the cGAS–STING pathway. The gene discussed is NFKB1; the disease is rheumatoid arthritis.